Omada Health, Inc. Amortization of Debt Issuance Costs
Omada Health, Inc. (OMDA) reported Amortization of Debt Issuance Costs of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AmortizationOfFinancingCosts · last filed 2026-08-07
- Omada Health, Inc. amortization of debt issuance costs for the quarter ending 2026-06-30 was $0.00, a 100.00% decline year-over-year.
- Omada Health, Inc. amortization of debt issuance costs for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- Omada Health, Inc. amortization of debt issuance costs for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- Omada Health, Inc. amortization of debt issuance costs for the quarter ending 2025-09-30 was $33.00K, a 66.33% decline year-over-year.
- Omada Health, Inc. amortization of debt issuance costs for fiscal 2025 was $285.00K, a 26.74% decline from fiscal 2024.
- Omada Health, Inc. amortization of debt issuance costs for fiscal 2024 was $389.00K, a 6.49% decline from fiscal 2023.
- Omada Health, Inc. amortization of debt issuance costs for fiscal 2023 was $416.00K.
| Period end | Amortization of Debt Issuance Costs 3 month | Amortization of Debt Issuance Costs 6 month | Amortization of Debt Issuance Costs 9 month | Amortization of Debt Issuance Costs 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $0.00 10-Q · filed 2026-08-07 | $0.00 derived: sum of 3 quarters · filed 2026-08-07 | $33.00K derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-08 | $0.00 derived: sum of 2 quarters · filed 2026-05-08 | $33.00K derived: sum of 3 quarters · filed 2026-05-08 | $176.00K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-06 | $33.00K derived: sum of 2 quarters · filed 2026-03-06 | $176.00K derived: sum of 3 quarters · filed 2026-08-07 | $285.00K 10-K · filed 2026-03-06 |
| 2025-09-30 | $33.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $176.00K derived: sum of 2 quarters · filed 2026-08-07 | $285.00K 10-Q · filed 2025-11-07 | $383.00K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | $143.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $252.00K 10-Q · filed 2026-08-07 | $350.00K derived: sum of 3 quarters · filed 2026-08-07 | $448.00K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | $109.00K 10-Q · filed 2026-05-08 | $207.00K derived: sum of 2 quarters · filed 2026-05-08 | $305.00K derived: sum of 3 quarters · filed 2026-05-08 | |
| 2024-12-31 | $98.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-06 | $196.00K derived: sum of 2 quarters · filed 2026-03-06 | $389.00K 10-K · filed 2026-03-06 | |
| 2024-09-30 | $98.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $291.00K 10-Q · filed 2025-11-07 | ||
| 2024-06-30 | $193.00K 10-Q · filed 2025-08-08 | |||
| 2023-12-31 | $416.00K 10-K · filed 2026-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |